Security key
M47238148
Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)
CUSIP: M47238148
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, NIS 1.80 par value per share
- Total 13F shares
- 1
- Total 13F value
- $1
- Share change
- 0
- SEC-reported price per share
- $1.00
- Number of holders
- 1
- Shares outstanding
- 5,591,387
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
GLMD full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M47238148
Recent filing periods:
Ownership snapshot
Top reported holders of GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
CVI Investments, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 3.1%
13D/G row: CVI Investments, Inc.
Showing 1-6 of 15 holder rows.
Quick read
CVI Investments, Inc. leads the comparable SEC ownership view at 3.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CVI Investments, Inc.'s linked filing trail.
Comparable ownership
Top 5
CVI Investments, Inc.
3.1%
Allen Baharaff
2.6%
TWO SIGMA INVESTMENTS, LP
1.4%
XTX Topco Ltd
0.4%
JANE STREET GROUP, LLC
0.29%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
3.1%
|
$346,666
173,333 shares
|
$0 | 30 Sep 2025 |
| Allen Baharaff |
3/4/5
13D/G
Chief Executive Officer, Director
|
2.6%
from 13D/G
|
$86,574
203,065 shares
mixed-class rows
|
— | 18 Mar 2026 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
1.4%
|
$39,287
80,177 shares
|
— | 31 Mar 2026 |
| XTX Topco Ltd |
13F
Company
|
0.4%
|
$10,822
22,396 shares
|
— | 31 Mar 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.29%
|
$8,058
16,445 shares
|
— | 31 Mar 2026 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.21%
|
$5,866
11,971 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
14
Q2 2026 holders
1
Holder diff
-13
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend